Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Esophageal and Lung Toxicities After Radiation (Chemo) Therapy for Lung Cancer Management

NCT04545658 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT04545658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04545658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Esophageal and Lung Toxicities After Radiation (Chemo) Therapy for Lung Cancer Management
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Completed
Start date
July 16, 2020
Completion date
July 31, 2020
Enrollment
167 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer